Grimmlab
@grimmlab
Followers
356
Following
108
Statuses
102
Research team at Heidelberg University (Germany) focusing on next-gen AAV & bocavirus vectors for human gene therapy #AAV #genetherapy #biotech #biotechnology
Heidelberg, Germany
Joined January 2021
Hats off to the Oliver Müller lab for their RNA-based directed evolution of novel AAV9 capsid variants for potent species-independent gene transfer to cardiomyocytes of mouse, rat or human origin 👍❤️🩹 Thx for the great collaboration & joint publication: 🤝
0
0
7
Honored to be a co-author w/ amazing colleagues from Universities Vienna, Stanford, Tübingen & Karolinska Institute on a review on cochlear gene therapy: Thx & congrats Lukas, Ellen, Francois, Steffen & Chris 🦻🤗 @CederrothCR @uni_tue @UniHeidelberg #AAV
0
1
8
Congrats to our 2 brilliant students - Anna Schneider & Lea Heckelmann - who graduated w/ a BSc in Biosciences & w/ top grades (1.0) 🥂👏 Fantastic work on new bocaviral vectors for human gene therapy (Anna) or optimized AAV vectors for antibody expression (Lea) 👍 @UniHeidelberg
0
0
6
Happy to see a "Research highlight" article written by our PhD student Jixin Liu published in Signal Transduction and Targeted Therapy: Well done, Jixin, and congratulations 😊👍 !
0
2
8
THX to all PhD students & speakers who made our "HBIGS Summer school 2024" on gene therapy such a success & so much fun 🤗☀️🍨🛳️🎳 ! Thx to @HBIGS_HD for funding & @RevvityLifeSci for extra support! Thx @DominikNiopek & Martina Weiss for the co-organization 🙌🫂 #genetherapy #AAV
1
0
10
Had a fantastic time at the XIX Parvovirus Workshop in Leuven (Belgium). Thx to Els Henckaerts & her local team - you did great 👍👏 Congrats to our PhD student Yumi Sano whose exciting work on new Bocavirus vectors attracted a lot of attention. More here:
0
0
14
RT @ERDERA_org: The European Rare Diseases Research Alliance @ERDERA_org kicks off with a bold vision to make Europe a global leader in ra…
0
36
0
Happy, humbled & honored that our lab is a partner in the new & comprehensive "European Rare Diseases Research Alliance - ERDERA" that unites >170 organizations from 37 countries in our joint ambition to deliver tangible solutions to rare diseases patients around the world 🤲🤝🫂
We are now ERDERA! This new partnership builds on EJPRD achivements to continue advancing diagnosis, prevention, and treatment research for the 30+ million people living with a rare disease in Europe and beyond. 👉
0
0
10
Excited that our collab w/ Wibke Bayer (@BayerWibke) & Matthias Vorgerd on a screen of antibodies against 18 AAV variants is published: Congrats to co-authors Ellen Wiedtke, Yumi Sano, Nico Fischer & Lisa Schiller (former) from our lab & all others 🤗 #AAV
0
0
9
Had an absolute blast with the whole lab playing Urban golf in a beautiful sunny area near Heidelberg, followed by après-golf lunch at Neuburg monastery. My heartfelt thanks to each & everyone of you for making this such a fun day & a fantastic team event to remember 🏑☀️🫂🙌🍜🍻
0
0
15
Thrilled that our work with Christian Buchholz (@PEI_Germany) & Petr Chlanda (@ChlandaL) on DARPin-modified AAVs for selective ex/in vivo targeting to CD8+ T-cells is now out in Molecular Therapy: Congrats to 1st author Burak & all co-authors 🙌🎉 #AAV
0
2
11
Thank you very much to Richard Horgan (@RichHorgan, 2nd from the right) & Ahna Gavrelos (right) from "Cure Rare Disease" (CRD, @CureRareDisease) for their visit to our lab, a great talk by Rich at our institute & a fun dinner in the old city 🥗🍖🥨🍻 Please support CRD 💪 ! #AAV
2
1
8
Happy that our joint article with Ulrike Protzer's lab (@ProtzerLab) on the use of AAV vectors for development of HBV mouse models is now out: Congrats to 1st author Lisa Schiller, our former MSc student & now PhD student in the Protzer lab 🎊🥂 #AAV #HBV
1
2
5
Congratulations to our postdoc Esra (co-supervised by Kerstin Göpfrich @KGoepfrich ) 👏👍
Very excited and honored to announce that I have been selected as a Young Marsilius Fellow for Interdisciplinary Research and Science Communication for the 2024/2025 academic term. Looking forward to meeting great scholars and doing lots of brainstorming for science communication
1
1
4
The 2nd in Communications Biology is from our collab with Klaus Überla's lab (@KUberla) incl 1st author Jannik Wagner & our partners at Sirion/Revvity incl Christian Thirion (@RevvityLifeSci @sirionbiotechmu): Congrats & thank you to all co-authors 🙏👏🥂
0
0
2
Congratulations to our PhD student Felix Bubeck who first-authored this article 🙌 !
Existing #Cas12a nucleases are too large for #AAV-based #GeneTherapy. @grimmlab explores a #PLOSBiology study of a new Cas12a variant, compatible with in vivo #GenomeEditing via all-in-one AAV delivery. Paper: Primer:
1
3
16
Interesting article on the Heidelberg Health & Life Science Alliance (@ResearchLifesci) including on the synthetic AAV / DNA origami vectors that we will develop together with Kerstin Göpfrich (@KGoepfrich) 🙌🧬 #AAV #genetherapy #origami @uniklinik_hd @mpi_mr_hd @UniHeidelberg
The Health and Life Science Alliance opens doors for early-career researchers. #AdFeature with @ResearchLifesci
1
3
12
Congrats to Marco Thürkauf (1st author), Randall Platt (@randall_platt), Markus Ruegg (@RueggLab) and all co-authors that this paper, which showcases the potential of our AAVMYO vector for in vivo gene knockouts, is now out in Nature Communications: ( #AAV
Thank you very much, too, Markus, Marco & Randall, for the unique opportunity to collaborate and to support your exciting & original project with our muscle-tropic AAV vector 🙏 ! Fingers crossed for the full submission 🤞👍 !! @RueggLab @randall_platt #AAV #GeneTherapy #Vector
1
0
9